Adial Pharmaceuticals Files 8-K

Ticker: ADIL · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1513525

Adial Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyAdial Pharmaceuticals, Inc. (ADIL)
Form Type8-K
Filed DateFeb 25, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, corporate-disclosure, financials

TL;DR

Adial Pharma filed an 8-K on Feb 25, 2025, covering financial statements and other events.

AI Summary

Adial Pharmaceuticals, Inc. filed an 8-K on February 25, 2025, reporting on various events. The filing includes information related to financial statements and exhibits, as well as other events and a Regulation FD disclosure. The company is incorporated in Delaware and its principal executive offices are located in Glen Allen, VA.

Why It Matters

This 8-K filing provides updates on Adial Pharmaceuticals' corporate activities and financial reporting, which are crucial for investors to assess the company's current status and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.

Key Players & Entities

  • Adial Pharmaceuticals, Inc. (company) — Registrant
  • Delaware (jurisdiction) — State of incorporation
  • Glen Allen, VA (location) — Address of principal executive offices
  • February 25, 2025 (date) — Date of earliest event reported

FAQ

What specific events are detailed in this 8-K filing?

The filing indicates it covers Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits, but the specific details of these events are not provided in the excerpt.

When was this 8-K report filed?

The report was filed on February 25, 2025.

What is Adial Pharmaceuticals, Inc.'s state of incorporation?

Adial Pharmaceuticals, Inc. is incorporated in Delaware.

Where are Adial Pharmaceuticals, Inc.'s principal executive offices located?

The principal executive offices are located at 4870 Sadler Road, Ste 300, Glen Allen, VA 23060.

What is the company's IRS Employer Identification Number?

The IRS Employer Identification Number is 82-3074668.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding ADIAL PHARMACEUTICALS, INC. (ADIL).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.